Veradigm Performance
| MDRXDelisted Stock | USD 13.33 0.02 0.15% |
The entity has a beta of -0.31, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Veradigm are expected to decrease at a much lower rate. During the bear market, Veradigm is likely to outperform the market. Veradigm right now has a risk of 0.0%. Please validate Veradigm potential upside, as well as the relationship between the accumulation distribution and price action indicator , to decide if Veradigm will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Veradigm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Veradigm is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 190.5 M |
Veradigm |
Veradigm Relative Risk vs. Return Landscape
If you would invest 1,333 in Veradigm on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Veradigm or generate 0.0% return on investment over 90 days. Veradigm is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Veradigm, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Veradigm Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Veradigm's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Veradigm, and traders can use it to determine the average amount a Veradigm's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MDRX |
Based on monthly moving average Veradigm is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Veradigm by adding Veradigm to a well-diversified portfolio.
Veradigm Fundamentals Growth
Veradigm Stock prices reflect investors' perceptions of the future prospects and financial health of Veradigm, and Veradigm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Veradigm Stock performance.
| Return On Equity | 0.0893 | ||||
| Return On Asset | 0.0216 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 395.97 M | ||||
| Shares Outstanding | 109.26 M | ||||
| Price To Earning | 3.87 X | ||||
| Price To Book | 0.57 X | ||||
| Price To Sales | 0.44 X | ||||
| Revenue | 1.5 B | ||||
| EBITDA | 362.9 M | ||||
| Cash And Equivalents | 500.16 M | ||||
| Cash Per Share | 4.51 X | ||||
| Total Debt | 434.5 M | ||||
| Debt To Equity | 0.18 % | ||||
| Book Value Per Share | 10.77 X | ||||
| Cash Flow From Operations | (75.4 M) | ||||
| Earnings Per Share | 0.86 X | ||||
| Total Asset | 2.43 B | ||||
| Retained Earnings | 767.56 M | ||||
| Current Asset | 538.35 M | ||||
| Current Liabilities | 512.96 M | ||||
About Veradigm Performance
Evaluating Veradigm's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Veradigm has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Veradigm has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people.Things to note about Veradigm performance evaluation
Checking the ongoing alerts about Veradigm for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Veradigm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Veradigm is not yet fully synchronised with the market data | |
| Veradigm has a very high chance of going through financial distress in the upcoming years | |
| Veradigm currently holds about 500.16 M in cash with (75.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.51. | |
| Over 97.0% of the company shares are owned by institutional investors |
- Analyzing Veradigm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Veradigm's stock is overvalued or undervalued compared to its peers.
- Examining Veradigm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Veradigm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Veradigm's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Veradigm's stock. These opinions can provide insight into Veradigm's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Veradigm Stock
If you are still planning to invest in Veradigm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Veradigm's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |